Liu Y, Wang K, Zhou Y, Zhuang X, Shao S, Qiao F, et al
Multi-peptide protocols increase expense significantly
Some gastrointestinal adverse events like viral gastroenteritis, feces hardness, and infrequent bowel movements were reported in a limited number of trials, restricting the ability to perform robust statistical analyses and draw definitive conclusions for those specific outcomes
Phase 2 data showed 24.2% mean weight loss at 48 weeks with 12 mg dose, the highest weight reduction reported for any single anti-obesity agent in Phase 2 trials, exceeding survodutide's 18.7%
(The FDA recommends setting refrigerators at or below 40 F.) However, the company also states that Wegovy can be stored with the pen cap on in temperatures up to 86 F for up to 28 days